A high yield, IMG friendly walkthrough of every urea cycle disorder NBME loves to test, built with mnemonics, diagrams, and ten Step 1 style MCQs.
Every IMG hits a wall the first time a urea cycle disorder shows up on UWorld. A neonate is lethargic. Ammonia is climbing. Orotic acid is in the urine. Suddenly we are choosing between five enzyme deficiencies that all sound identical, we freeze, click the wrong answer, and lose a question we should have owned.
We see this pattern every cycle at IMG Helping Hands. The urea cycle is not actually difficult. It has six enzymes, two compartments, and three lab patterns. The problem is that most of us learn it backwards: we memorise the disorders before we understand the cycle. By the end of this guide, that flips. We will walk through the cycle the way NBME tests it, lock every disorder in with mnemonics that survive exam day stress, and finish with ten vignette MCQs that mirror the real Step 1 question style.
By the time we are done, we will never again confuse OTC deficiency with hereditary orotic aciduria, and we will read a hyperammonemia vignette and know the answer before we reach the lead in.
Step 1 is pass/fail, but the bar is not soft. The current USMLE Step 1 content outline distributes biochemistry across two large blueprint sections: Biochemistry and Nutrition (its own dedicated section) and Multisystem Processes and Disorders, where inborn errors of metabolism live. Together, biochemistry flavoured content lands somewhere in the 14 to 18 percent range of any given form. Urea cycle disorders sit inside that range and recur on essentially every NBME practice form.
Pass/fail framing changes the consequences, not the content. A borderline test taker who whiffs an entire high yield biochem block, urea cycle included, can fail. NBME writers love urea cycle disorders because the vignettes integrate cleanly with neonatology, neurology, pharmacology (think valproate), and even nutrition (the protein rich meal trigger). One topic, four cross references, infinite question variants.
The classic stem is predictable: a newborn becomes lethargic 24 to 72 hours after birth, feeds poorly, vomits, develops tachypnea (respiratory alkalosis from ammonia stimulating the brainstem), and progresses to seizure or coma. Labs show high ammonia, low BUN, and a metabolic profile that points us at one specific enzyme. We learn the pattern once, we get the question every time.
Build it once. Never forget it.
Every amino acid we eat or break down releases an amino group. That nitrogen becomes ammonia (NH₃), which is neurotoxic at even modest concentrations. The brain is the first organ to fail because ammonia pulls glutamate into glutamine, depleting glutamate (the major excitatory neurotransmitter and a TCA precursor via alpha-ketoglutarate) and causing astrocyte swelling. The liver fixes this by packaging ammonia into urea, a non toxic, water soluble molecule the kidneys excrete.
• Tissue: Hepatocytes (periportal zone). Skeletal muscle handles nitrogen via the glucose-alanine cycle, but only the liver makes urea.
• Compartments: The first two reactions sit in the mitochondrial matrix. The remaining three sit in the cytosol. Citrulline crosses the inner mitochondrial membrane outward; ornithine crosses inward to keep the cycle running.
• CPS-I (Carbamoyl Phosphate Synthetase I) : mitochondrial. Combines NH₃ + CO₂ + 2 ATP to form carbamoyl phosphate. Activated by N-acetylglutamate (NAG).
• OTC (Ornithine Transcarbamylase) : mitochondrial. Joins carbamoyl phosphate with ornithine to form citrulline. The only X-linked enzyme of the cycle.
• ASS (Argininosuccinate Synthetase) : cytosolic. Joins citrulline with aspartate (this is where the second nitrogen enters) to form argininosuccinate.
• ASL (Argininosuccinate Lyase) : cytosolic. Splits argininosuccinate into arginine and fumarate (which feeds the TCA cycle, linking urea cycle and TCA : the so called aspartate-argininosuccinate shunt).
• Arginase : cytosolic. Cleaves arginine into urea + ornithine. Ornithine returns to the mitochondrion to restart the cycle.
CPS-I is the rate limiting enzyme of the urea cycle, and it does nothing without N-acetylglutamate. NAG is synthesised from glutamate and acetyl-CoA by N-acetylglutamate synthase (NAGS), and NAGS is allosterically activated by arginine. When dietary protein is high, glutamate and arginine both rise, NAG rises, CPS-I activates, and the cycle accelerates. When NAGS is broken, the entire cycle stalls ; and we see hyperammonemia that mimics CPS-I deficiency exactly.
Figure 1. The urea cycle : master flowchart. Two compartments, five enzymes, one regulator. NAG (green) activates CPS-I to launch the cycle.
We cover all six urea cycle disorders. Three patterns predict the disease almost every time: ammonia level, citrulline level, and orotic acid in urine.
Figure 2. Hepatocyte compartments. When OTC fails, carbamoyl phosphate spills into the cytosolic pyrimidine pathway and produces orotic acid : the hallmark of OTC deficiency.
• Inheritance: Autosomal recessive.
• Defect: Cannot make NAG, so CPS-I has no activator and shuts down.
• Accumulates: Ammonia. Citrulline is low. Orotic acid is normal.
• Presentation: Neonatal hyperammonemia, indistinguishable from CPS-I clinically.
• Differentiator: Responds to N-carbamylglutamate (carglumic acid), a NAG analogue that bypasses the missing enzyme. CPS-I deficiency does not respond.
• NBME hook: If a vignette describes a neonate with hyperammonemia who improves dramatically on carglumic acid, the answer is NAGS.
• Inheritance: Autosomal recessive.
• Defect: First mitochondrial step blocked. Ammonia cannot enter the cycle.
• Accumulates: Ammonia (very high). Citrulline is low. Orotic acid is normal or low.
• Presentation: Severe neonatal hyperammonemia within 24 to 72 hours, lethargy, vomiting, tachypnea (respiratory alkalosis), seizures, coma.
• Treatment: Restrict protein, give sodium benzoate and sodium phenylacetate (or phenylbutyrate), supplement arginine, hemodialysis if ammonia is dangerously high.
• NBME trap: Differentiated from NAGS by failure to respond to carglumic acid.
If we remember nothing else, we remember OTC. It is the most common urea cycle disorder, the only X-linked one, and the highest yield biochem topic in this entire chapter.
• Inheritance: X-linked recessive (the only one). Affected males present in the neonatal period; female carriers can present later in life with protein load triggers (high protein meal, surgery, postpartum stress, valproate).
• Defect: Carbamoyl phosphate cannot combine with ornithine, so it accumulates and spills back into the cytosol, where it enters the pyrimidine synthesis pathway and is converted into orotic acid.
• Accumulates: Ammonia (high). Carbamoyl phosphate (high, drives orotic acid). Orotic acid in urine and blood (high). Citrulline is low. BUN is low.
• Presentation: Neonate with vomiting, tachypnea, lethargy 24 to 72 hours after birth. Older children or adults with episodic confusion, ataxia, or unexplained encephalopathy after high protein meals.
• Labs: High ammonia, low BUN, high urinary orotic acid, normal hematocrit and MCV (no megaloblastic anemia ; this is the clincher).
• Treatment: Low protein diet, sodium benzoate, sodium phenylbutyrate, arginine or citrulline supplementation, dialysis for crises.
• NBME hook: Boy with hyperammonemia and orotic acid in urine but no megaloblastic anemia? OTC. Every time.
• Inheritance: Autosomal recessive.
• Defect: Citrulline cannot combine with aspartate.
• Accumulates: Citrulline (very high in plasma and urine). Ammonia is high.
• Presentation: Classic neonatal hyperammonemia within the first week of life.
• Treatment: Same nitrogen scavenger backbone (benzoate, phenylbutyrate), plus arginine supplementation.
• NBME hook: Plasma citrulline is markedly elevated , that single lab points at ASS.
• Inheritance: Autosomal recessive.
• Defect: Argininosuccinate cannot be split into arginine and fumarate.
• Accumulates: Argininosuccinate (urine and plasma). Citrulline is moderately high. Ammonia is high.
• Presentation: Hyperammonemia, plus a unique long term feature: trichorrhexis nodosa (brittle hair) from arginine deficiency.
• Treatment: Nitrogen scavengers, arginine supplementation (especially important here since arginine is essentially the end product the patient cannot make).
• NBME hook: Brittle hair plus elevated argininosuccinate equals ASL deficiency.
• Inheritance: Autosomal recessive.
• Defect: Arginine cannot be cleaved into urea and ornithine.
• Accumulates: Arginine. Ammonia rises but typically less dramatically than other urea cycle defects.
• Presentation: Very different from the rest. Instead of acute neonatal coma, patients present at 1 to 3 years of age with progressive spastic diplegia, growth failure, and seizures. Mimics cerebral palsy.
• Treatment: Strict low protein, low arginine diet, plus nitrogen scavengers.
• NBME hook: Toddler with spastic diplegia and high arginine ; answer is arginase deficiency, not cerebral palsy.
Figure 3. The clinical decision tree for neonatal hyperammonemia. Three lab values (ammonia, citrulline, urinary orotic acid) localise the block with near perfect accuracy.
This is the single most tested NBME trap in the urea cycle chapter. Both diseases dump orotic acid into the urine. Both are paediatric. Yet the answer is always one or the other, never both. We tell them apart in five seconds with the table below.
| Feature | OTC deficiency | Hereditary orotic aciduria |
| Defective enzyme | Ornithine transcarbamylase (urea cycle) | UMP synthase (pyrimidine de novo synthesis) |
| Inheritance | X-linked recessive | Autosomal recessive |
| Ammonia | HIGH | Normal |
| Orotic acid in urine | HIGH | HIGH |
| Megaloblastic anemia | ABSENT | PRESENT (refractory to B12 / folate) |
| Failure to thrive | Variable | Yes, with anemia |
| Treatment | Low protein, scavengers, arginine | Uridine supplementation |
| NBME TRAP : One Line Killer Hyperammonemia + orotic acid + no megaloblastic anemia = OTC deficiency Normal ammonia + orotic acid + megaloblastic anemia refractory to B12/folate = hereditary orotic aciduria If we lock just this one fact down, we never miss either question again. |
Figure 4. The visual lock down for the OTC vs. hereditary orotic aciduria trap. Same urine finding, opposite origins.
• Stop protein intake immediately. The ongoing source of nitrogen has to be cut off.
• IV glucose with insulin if needed to halt catabolism, because muscle breakdown floods the system with more amino acids.
• Nitrogen scavengers: Sodium benzoate (binds glycine, excreted as hippurate). Sodium phenylacetate or phenylbutyrate (binds glutamine, excreted as phenylacetylglutamine). Both bypass the urea cycle entirely.
• Arginine or citrulline : replaces what the broken cycle can no longer make. Citrulline is preferred when the block is upstream of ASS (NAGS, CPS-I, OTC); arginine works for ASS, ASL.
• Hemodialysis if ammonia is rising rapidly or above the threshold for neurotoxicity (often >500 micromol/L in neonates).
• Carglumic acid specifically rescues NAGS deficiency and certain organic acidemias that secondarily inhibit NAGS (propionic acidemia, methylmalonic acidemia).
• Lifelong protein restricted diet titrated to growth and ammonia.
• Daily nitrogen scavenger therapy (oral phenylbutyrate or glycerol phenylbutyrate).
• Arginine or citrulline depending on the block.
• Avoid valproate (it inhibits CPS-I and N-acetylglutamate synthase ; classic NBME crossover).
• Avoid catabolic stressors: prolonged fasting, infection without prompt glucose support, postpartum stress.
• Liver transplantation for severe disease, particularly OTC.
| CROSSOVER ALERT : Valproate Valproate inhibits carbamoyl phosphate synthetase I and depletes carnitine, precipitating hyperammonemia even in patients with no known urea cycle disorder. In a female carrier of OTC, valproate can unmask the disease as the first presentation in adulthood. If we see encephalopathy after starting valproate, we check ammonia first. |
Figure 5. The hyperammonemia treatment ladder. Climb in order. Each rung adds a specific intervention.
| MNEMONIC 1 : The cycle itself“Ordinarily, Careless Crappers Are Also Frivolous About Urination” Ornithine → Carbamoyl phosphate → Citrulline → Aspartate → Argininosuccinate → Fumarate → Arginine → Urea. Walk this once before every NBME and the cycle never slips. |
| MNEMONIC 2 : The five enzymes in order“Cops Often Avoid Annoying Arguments” CPS-I → OTC → ASS → ASL → Arginase. Pairs perfectly with the substrate mnemonic above. Together they reconstruct the cycle from memory in under thirty seconds. |
| MNEMONIC 3 : Which disorders cause high orotic acid?“Only OTC Has Hyperammonemia, Only Orotic Aciduria Has Anemia” Two diseases dump orotic acid in urine. OTC has high ammonia and no anemia. Hereditary orotic aciduria has normal ammonia and megaloblastic anemia. Memorise this one sentence and the trap question dies. |
| MNEMONIC 4 : Lab pattern triage“Citrulline tells the story.” LOW citrulline + HIGH orotic acid = OTC. LOW citrulline + NORMAL orotic acid = CPS-I or NAGS. HIGH citrulline alone = citrullinemia (ASS). HIGH argininosuccinate (with brittle hair) = ASL deficiency. HIGH arginine (with spastic diplegia) = arginase deficiency. |
| MNEMONIC 5 : Treatment drugs“Ben And Phil Save the Baby” Ben = sodium Benzoate (binds glycine). Phil = sodium phenylacetate / phenylbutyrate (binds glutamine). Both shuttle nitrogen out of the body without going through the urea cycle. Add arginine or citrulline depending on where the block sits. |
Every diagram referenced in the preceding sections is collected here in one place for quick review before exam day. Each one targets one specific exam pattern.
• Figure 1: the master urea cycle flowchart : two compartments, five enzymes, NAG as the regulator.
• Figure 2: hepatocyte compartments : why OTC failure produces orotic acid.
• Figure 3: decision tree for neonatal hyperammonemia : the highest yield clinical algorithm.
• Figure 4: OTC vs hereditary orotic aciduria side by side : the NBME’s favourite trap.
• Figure 5: the treatment ladder : five rungs in order, plus what to avoid.
| Disorder | Enzyme | Inheritance | Ammonia | Citrulline | Orotic acid | Hallmark |
| NAGS def. | N-acetylglutamate synthase | AR | High | Low | Normal | Responds to carglumic acid |
| CPS-I def. | Carbamoyl phosphate synthetase I | AR | High | Low | Normal/Low | Severe neonatal coma |
| OTC def. | Ornithine transcarbamylase | X-linked R | High | Low | HIGH | Most common; no anemia |
| Citrullinemia | Argininosuccinate synthetase (ASS) | AR | High | VERY HIGH | Normal/High | Markedly elevated citrulline |
| Argininosuccinic aciduria | Argininosuccinate lyase (ASL) | AR | High | Mod high | Normal | Brittle hair (trichorrhexis) |
| Argininemia | Arginase | AR | Modest | Normal | Normal | Spastic diplegia, late onset |
| Drug | Mechanism | Use |
| Sodium benzoate | Binds glycine to form hippurate; excreted in urine | Removes nitrogen, all UCDs |
| Sodium phenylacetate / phenylbutyrate | Binds glutamine to form phenylacetylglutamine; excreted in urine | Removes nitrogen, all UCDs |
| Glycerol phenylbutyrate | Oral prodrug of phenylbutyrate | Chronic management |
| Arginine | Replaces deficient arginine, also enhances flux | ASS, ASL deficiency |
| Citrulline | Bypasses CPS-I and OTC blocks | NAGS, CPS-I, OTC deficiency |
| Carglumic acid (N-carbamylglutamate) | NAG analogue, activates CPS-I | NAGS deficiency; organic acidemias with secondary NAGS inhibition |
| Hemodialysis | Direct removal of ammonia | Acute crisis with ammonia >500 |
| Block at… | Substrate that piles up | Substrate that drops |
| NAGS | Ammonia | NAG, then everything downstream |
| CPS-I | Ammonia | Carbamoyl phosphate and below |
| OTC | Carbamoyl phosphate (overflows into pyrimidine pathway → orotic acid), ammonia | Citrulline, arginine, urea |
| ASS | Citrulline, ammonia | Argininosuccinate, arginine, urea |
| ASL | Argininosuccinate, ammonia | Arginine (deficiency causes brittle hair) |
| Arginase | Arginine | Urea, ornithine |
| Top 7 traps the NBME loves to plant 1. Respiratory alkalosis in a sick neonate ; points to ammonia (urea cycle) over organic acidemia (which causes metabolic acidosis with anion gap). 2. Orotic acid in urine without anemia = OTC. With megaloblastic anemia = hereditary orotic aciduria. 3. Female adult with episodic confusion after a steak dinner : manifesting heterozygote OTC carrier. 4. Encephalopathy after valproate : valproate induced hyperammonemia, often unmasking OTC. 5. Brittle, fragile hair (trichorrhexis nodosa) in a child with hyperammonemia = ASL deficiency. 6. Toddler with spastic diplegia and seizures, mimics cerebral palsy = arginase deficiency. Easy to miss. 7. Postpartum encephalopathy protein catabolism after delivery can unmask female OTC carriers. Tested in obstetrics flavoured vignettes. |
| PRINT AND PIN : The entire urea cycle chapter on one page Cycle order: CPS-I → OTC → ASS → ASL → Arginase. Mnemonic: “Cops Often Avoid Annoying Arguments.” Substrate order: Ornithine → Carbamoyl P → Citrulline → Aspartate → Argininosuccinate → Fumarate → Arginine → Urea. Mnemonic: “Ordinarily, Careless Crappers Are Also Frivolous About Urination.” Compartments: first two enzymes (CPS-I, OTC) mitochondrial; last three (ASS, ASL, Arginase) cytosolic. Rate limiting: CPS-I, activated by N-acetylglutamate (NAG); NAGS activated by arginine. OTC = X-linked. Everything else = autosomal recessive. Lab signature: hyperammonemia + low BUN + respiratory alkalosis = urea cycle disorder. OTC vs orotic aciduria: both have orotic acid. OTC has high ammonia, no anemia. Orotic aciduria has normal ammonia, megaloblastic anemia refractory to B12/folate, treated with uridine. Citrullinemia (ASS): citrulline very high in plasma. ASL deficiency: brittle hair (trichorrhexis). Arginase deficiency: spastic diplegia in a toddler, mimics CP. Acute treatment: stop protein, IV glucose, sodium benzoate, sodium phenylbutyrate, arginine/citrulline, dialysis if severe, carglumic acid for NAGS. Avoid: valproate (inhibits CPS-I and NAGS). |
A 3 day old male infant is brought to the emergency department for poor feeding, lethargy, and tachypnea. He was born at term to non consanguineous parents. Physical examination shows hypotonia and decreased responsiveness. Arterial blood gas reveals pH 7.52, pCO₂ 26 mmHg, HCO₃ 22 mEq/L. Serum ammonia is 480 micromol/L (normal <50). Serum BUN is low. Urinary orotic acid is markedly elevated. There is no anemia. Which of the following enzymes is most likely deficient?
Question: Which of the following is most likely the correct answer?
A. Carbamoyl phosphate synthetase I
B. Ornithine transcarbamylase
C. Argininosuccinate synthetase
D. UMP synthase
E. Arginase
Correct answer: B. Ornithine transcarbamylase
Explanation: The neonate has classic urea cycle hyperammonemia: respiratory alkalosis (ammonia stimulates the medullary respiratory centre), low BUN, and high urinary orotic acid without anemia. Carbamoyl phosphate cannot enter the cycle, overflows into cytosolic pyrimidine synthesis, and produces orotic acid. CPS-I deficiency (A) does not produce high orotic acid because carbamoyl phosphate is never made. ASS deficiency (C) raises citrulline. UMP synthase deficiency (D) causes megaloblastic anemia and orotic aciduria with normal ammonia. Arginase deficiency (E) presents later with spastic diplegia, not neonatal coma.
| Teaching point: Hyperammonemia + orotic acid + no megaloblastic anemia = OTC deficiency. |
A 28 year old woman with a long history of generalised epilepsy is started on valproic acid. Two weeks later she presents to the emergency department with confusion, slurred speech, and asterixis. Her family reports that she had similar episodes after high protein meals during her teenage years that resolved spontaneously. Serum ammonia is 220 micromol/L. Liver enzymes are normal.
Question: Which of the following is most likely the correct answer?
A. Acute valproate hepatotoxicity
B. Manifesting heterozygote of an X-linked urea cycle disorder
C. Hereditary orotic aciduria
D. Wilson disease
E. Hepatic encephalopathy from cirrhosis
Correct answer: B. Manifesting heterozygote of an X-linked urea cycle disorder
Explanation: OTC deficiency is X-linked. Female heterozygotes have variable expression depending on lyonization. Symptoms emerge with protein loads, postpartum stress, or drugs that further inhibit the cycle, valproate inhibits CPS-I and NAGS, precipitating the crisis. Liver enzymes are normal, ruling out hepatotoxicity (A). Hereditary orotic aciduria (C) has megaloblastic anemia, not adult onset encephalopathy. Wilson disease (D) presents with neuropsychiatric features but with abnormal LFTs and Kayser-Fleischer rings. Cirrhosis (E) requires evidence of chronic liver disease.
| Teaching point: Valproate + new encephalopathy + protein-meal history = check ammonia, suspect OTC carrier. |
A 2 day old female neonate develops vomiting and lethargy. Examination is unremarkable except for hypotonia. Serum ammonia is 620 micromol/L. Plasma citrulline is markedly elevated. Plasma argininosuccinate is undetectable. Urinary orotic acid is mildly elevated.
Question: Which of the following is most likely the correct answer?
A. CPS-I deficiency
B. OTC deficiency
C. Citrullinemia type I
D. Argininosuccinic aciduria
E. Arginase deficiency
Correct answer: C. Citrullinemia type I
Explanation: Markedly elevated plasma citrulline with absent argininosuccinate localises the block to ASS: the enzyme that condenses citrulline with aspartate to form argininosuccinate. CPS-I (A) and OTC (B) both have LOW citrulline. ASL deficiency (D) has elevated argininosuccinate. Arginase deficiency (E) presents later with spastic diplegia, not neonatal coma.
| Teaching point: Plasma citrulline very high, argininosuccinate absent → ASS deficiency (citrullinemia). |
A 5 day old infant presents with feeding intolerance, lethargy, and seizures. Ammonia is 750 micromol/L. Plasma citrulline is moderately elevated. Argininosuccinate is markedly elevated. On follow up at 6 months of age, the child is noted to have brittle, fragile hair that breaks easily. The deficient enzyme catalyses which of the following reactions?
Question: Which of the following is most likely the correct answer?
A. NH₃ + CO₂ + 2 ATP → carbamoyl phosphate
B. Ornithine + carbamoyl phosphate → citrulline
C. Citrulline + aspartate → argininosuccinate
D. Argininosuccinate → arginine + fumarate
E. Arginine → urea + ornithine
Correct answer: D. Argininosuccinate → arginine + fumarate
Explanation: Trichorrhexis nodosa (brittle hair) plus elevated argininosuccinate is pathognomonic for ASL deficiency. ASL splits argininosuccinate into arginine and fumarate, linking the urea cycle to the TCA cycle (the aspartate argininosuccinate shunt). The hair finding reflects functional arginine deficiency, since arginine cannot be regenerated. Choice A is CPS-I, B is OTC, C is ASS, E is arginase.
| Teaching point: Brittle hair + hyperammonemia + high argininosuccinate = ASL deficiency. |
A 2-year-old boy is brought for evaluation of progressive lower-extremity stiffness, frequent falls, and developmental delay. He is in the 5th percentile for height and weight. Examination shows hyperreflexia, scissoring gait, and mild ankle clonus. Initial workup for cerebral palsy is unrevealing. Serum ammonia is 110 micromol/L. Plasma arginine is markedly elevated. Urinary orotic acid is normal.
Question: Which of the following is most likely the correct answer?
A. CPS-I deficiency
B. OTC deficiency
C. Citrullinemia
D. Arginase deficiency
E. Cerebral palsy due to perinatal hypoxic ischemic injury
Correct answer: D. Arginase deficiency
Explanation: Arginase deficiency uniquely presents not as neonatal coma but as progressive spastic diplegia and seizures in toddlers. Plasma arginine is elevated, and ammonia rises only modestly. The clinical picture mimics cerebral palsy and is often misdiagnosed. The other urea cycle defects present in the neonatal period with severe hyperammonemia.
| Teaching point: Toddler with spastic diplegia + high arginine = arginase deficiency, not CP. |
A 4-day old male neonate has serum ammonia of 580 micromol/L. Plasma citrulline is low. Urinary orotic acid is normal. Empiric carglumic acid is administered, and within hours the ammonia falls to 80 micromol/L.
Question: Which of the following is most likely the correct answer?
A. N-acetylglutamate synthase
B. Carbamoyl phosphate synthetase I
C. Ornithine transcarbamylase
D. Argininosuccinate synthetase
E. Arginase
Correct answer: A. N-acetylglutamate synthase
Explanation: Both NAGS and CPS-I deficiency present with hyperammonemia, low citrulline, and normal orotic acid. The decisive differentiator is response to carglumic acid (N-carbamylglutamate), a NAG analogue that activates CPS-I directly. NAGS deficiency responds dramatically; CPS-I does not, because the enzyme itself is broken. OTC (C) would have high orotic acid. ASS (D) would have high citrulline. Arginase (E) presents in toddlers, not neonates.
| Teaching point: Carglumic acid response differentiates NAGS deficiency from CPS-I deficiency. |
A 2 year old girl presents with failure to thrive, pallor, and developmental delay. CBC reveals megaloblastic anemia with MCV 112 fL. Serum vitamin B12 and folate are normal. Trial of high dose B12 and folate has failed to correct the anemia. Urinary orotic acid is markedly elevated. Serum ammonia is normal. Which of the following is the most appropriate treatment?
Question: Which of the following is most likely the correct answer?
A. Sodium benzoate and phenylbutyrate
B. Arginine supplementation
C. Carglumic acid
D. Uridine supplementation
E. Liver transplantation
Correct answer: D. Uridine supplementation
Explanation: This is hereditary orotic aciduria (UMP synthase deficiency), not a urea cycle disorder. Pyrimidine synthesis is blocked, producing megaloblastic anemia refractory to B12 and folate, with high urinary orotic acid but normal ammonia. Uridine bypasses the block. The other choices target urea cycle defects, which would have hyperammonemia.
| Teaching point: Orotic acid + megaloblastic anemia + normal ammonia = hereditary orotic aciduria. Treat with uridine. |
A 3 day old neonate has serum ammonia of 950 micromol/L despite protein restriction, IV dextrose, sodium benzoate, sodium phenylacetate, and arginine. Mental status continues to deteriorate. Which of the following is the most appropriate next step?
Question: Which of the following is most likely the correct answer?
A. Increase phenylacetate dose
B. Add carglumic acid
C. Initiate hemodialysis
D. Begin lactulose
E. Administer rifaximin
Correct answer: C. Initiate hemodialysis
Explanation: When ammonia exceeds approximately 500 micromol/L in a neonate or rises despite maximal scavenger therapy, hemodialysis is indicated to physically remove ammonia and prevent permanent neurologic injury. Carglumic acid (B) is appropriate for NAGS deficiency or organic acidemias but does not replace dialysis when ammonia is critically high. Lactulose (D) and rifaximin (E) are for hepatic encephalopathy in liver disease, not for inborn urea cycle defects.
| Teaching point: Ammonia >500 micromol/L in a neonate or rising despite scavengers = hemodialysis. |
A 30 year old woman presents to the emergency department on postpartum day 4 with confusion, agitation, and a single tonic clonic seizure. Her pregnancy was uncomplicated. Serum ammonia is 310 micromol/L. AST and ALT are normal. There is no history of liver disease. Family history reveals that her older brother died at 5 days of age of “unexplained encephalopathy.” Which of the following findings would most strongly support the suspected diagnosis?
Question: Which of the following is most likely the correct answer?
A. Elevated plasma citrulline
B. Elevated plasma argininosuccinate
C. Elevated urinary orotic acid
D. Elevated plasma arginine
E. Elevated serum ceruloplasmin
Correct answer: C. Elevated urinary orotic acid
Explanation: The combination of postpartum hyperammonemia, normal liver enzymes, and a brother who died in the neonatal period of unexplained encephalopathy points squarely at OTC deficiency in a manifesting female heterozygote. Postpartum protein catabolism unmasks carriers. The hallmark lab is elevated urinary orotic acid with normal hematocrit. Citrulline (A) is high in citrullinemia. Argininosuccinate (B) is high in ASL deficiency. Arginine (D) is high in arginase deficiency. Ceruloplasmin (E) is for Wilson disease.
| Teaching point: Postpartum hyperammonemia + neonatal death of male sibling = OTC manifesting carrier. |
A research investigator is studying a hepatocyte cell line with a knockout of N-acetylglutamate synthase. Compared with wild type cells, the mutant cells are exposed to identical concentrations of ammonia, ATP, ornithine, and aspartate. Which of the following changes in urea cycle intermediate concentrations is most likely?
Question: Which of the following is most likely the correct answer?
A. Increased carbamoyl phosphate, decreased citrulline
B. Decreased carbamoyl phosphate, decreased citrulline
C. Increased citrulline, decreased argininosuccinate
D. Increased argininosuccinate, decreased arginine
E. Increased arginine, decreased ornithine
Correct answer: B. Decreased carbamoyl phosphate, decreased citrulline
Explanation: Without NAG, CPS-I is essentially inactive. Carbamoyl phosphate cannot be synthesised, so it falls. Without carbamoyl phosphate, OTC has nothing to combine with ornithine, so citrulline also falls. This pattern (low carbamoyl phosphate, low citrulline, no orotic aciduria) distinguishes NAGS deficiency from OTC deficiency, where carbamoyl phosphate accumulates because CPS-I is intact and produces it normally , but OTC cannot use it, so it overflows into pyrimidine synthesis. Choice A describes OTC, not NAGS.
| Teaching point: NAGS knockout = CPS-I has no activator = carbamoyl phosphate AND citrulline both fall. Distinct from OTC, where carbamoyl phosphate piles up. |
IMG HELPING HANDS – USMLE STEP 1 BIOCHEMISTRY SERIES
The cycle has six enzymes, two compartments, and three lab patterns. Once you understand these patterns, the disorders become automatic to solve on NBME-style questions. This guide is part of our IMGHH Step 1 biochemistry series designed to help you master high-yield concepts without memorization overload.
We continue building full coverage for glycogen storage diseases, rate-limiting enzymes, lysosomal storage disorders, and the complete Step 1 biochemistry map.
We are IMG Helping Hands, the resource we wished we had when we started NBME prep.
Step 1 is changing. Your preparation strategy should too.
Yes. The current Step 1 content outline distributes biochemistry across the Biochemistry and Nutrition section and the Multisystem Processes and Disorders section, together accounting for roughly 14 to 18 percent of any given form. Pass/fail does not soften the bar ; borderline test takers fail when they whiff entire biochem blocks. Inborn errors of metabolism, including urea cycle disorders, are recurring favourites.
OTC deficiency, by a wide margin. It is the only X-linked urea cycle defect, the most common one overall, and it is the only urea cycle disorder that produces orotic acid in the urine. NBME writers love it because it integrates with neonatology, pharmacology (valproate), and pyrimidine biochemistry.
Both produce orotic acid in urine. OTC deficiency has high ammonia and no megaloblastic anemia. Hereditary orotic aciduria has normal ammonia and megaloblastic anemia refractory to B12 and folate. Treatment also separates them: nitrogen scavengers and arginine for OTC, uridine supplementation for orotic aciduria.
Valproate inhibits carbamoyl phosphate synthetase I and depletes carnitine, which is required for fatty acid oxidation that supports the urea cycle. In otherwise healthy patients this rarely causes a problem, but in OTC carriers (especially female heterozygotes) it can unmask the disease and precipitate encephalopathy. We always check ammonia in any patient who develops mental status changes after starting valproate.
We use three layered mnemonics. “Cops Often Avoid Annoying Arguments” gives the enzyme order (CPS-I, OTC, ASS, ASL, Arginase). “Ordinarily, Careless Crappers Are Also Frivolous About Urination” gives the substrate order. Then we triage by labs: low citrulline plus high orotic acid means OTC, low citrulline plus normal orotic acid means CPS-I or NAGS, high citrulline alone means citrullinemia; high argininosuccinate with brittle hair means ASL, high arginine with spastic diplegia means arginase deficiency.
Articles published by IMG Helping Hands are prepared by our team using information from direct experience, publicly available resources, and educational references. AI tools may be used to assist with drafting, proofreading, and formatting; however, all content undergoes review and approval before publication.
The information provided is intended for educational purposes only. Requirements, policies, and processes may change over time. Readers should consult official sources for the most current information.
Get our most valuable tips right inside your inbox, once per month!
